These results are consistent with the paucity of oncogene activation reported in MM [7,8,9] and also indicate that MET-mutations or -fusions are unlikely to be the cause of MET overexpression in samples without MET-GCNG/GA. Here, MET is linked to Miyoshi myopathy.